Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Miller

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Gastroenterology|August 1, 2017
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver ForumYuval A Patel, Joanne C Imperial, Andrew J Muir, et al.
AIDS (London, England)|September 28, 2002
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyGilbert Greub, Alessandro Cozzi-Lepri, Bruno Ledergerber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical TrialsRoy F Chemaly, Tali Shafat, Anna Wald, et al.
The Lancet. Microbe|December 27, 2025
Strengthening hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political willMitchell Leus, Chukwunomso E Osakwe, Danjuma Adda, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Lancet (London, England)|November 1, 2025
Challenges and opportunities in developing integrated sexual and reproductive health programmesKenneth H Mayer, Chris Beyrer, Myron S Cohen, et al.
AIDS (London, England)|November 6, 2003
Monitoring of long-term toxicities of HIV treatments: an international perspectiveGreg Bisson, Robert Gross, Veronica Miller, et al.
Nature Reviews. Gastroenterology & Hepatology|October 7, 2022
Nomenclature of HBV core protein-targeting antiviralsFabien Zoulim, Adam Zlotnick, Stephanie Buchholz, et al.
Journal of the American College of Cardiology|February 4, 2026
MASLD, MASH, and the CKM Spectrum: A Roadmap for Multiorgan Clinical Trial DesignFaiez Zannad, Muhammad Shahzeb Khan, Nisha Bansal, et al.
Gastroenterology|September 15, 2019
Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver DiseaseMiriam B Vos, Lara Dimick-Santos, Ruby Mehta, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Gastroenterology|August 1, 2017
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver ForumYuval A Patel, Joanne C Imperial, Andrew J Muir, et al.
AIDS (London, England)|September 28, 2002
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyGilbert Greub, Alessandro Cozzi-Lepri, Bruno Ledergerber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical TrialsRoy F Chemaly, Tali Shafat, Anna Wald, et al.
The Lancet. Microbe|December 27, 2025
Strengthening hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political willMitchell Leus, Chukwunomso E Osakwe, Danjuma Adda, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Lancet (London, England)|November 1, 2025
Challenges and opportunities in developing integrated sexual and reproductive health programmesKenneth H Mayer, Chris Beyrer, Myron S Cohen, et al.
AIDS (London, England)|November 6, 2003
Monitoring of long-term toxicities of HIV treatments: an international perspectiveGreg Bisson, Robert Gross, Veronica Miller, et al.
Nature Reviews. Gastroenterology & Hepatology|October 7, 2022
Nomenclature of HBV core protein-targeting antiviralsFabien Zoulim, Adam Zlotnick, Stephanie Buchholz, et al.
Journal of the American College of Cardiology|February 4, 2026
MASLD, MASH, and the CKM Spectrum: A Roadmap for Multiorgan Clinical Trial DesignFaiez Zannad, Muhammad Shahzeb Khan, Nisha Bansal, et al.
Gastroenterology|September 15, 2019
Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver DiseaseMiriam B Vos, Lara Dimick-Santos, Ruby Mehta, et al.
Pageof 11